9 Oorjita research notes discuss Cipla.
Despite flat index performance, more stocks declined (1672) than advanced (1494), indicating weak internal market strength. This suggests the market move was concentrated in a few heavyweight stocks.
1 advancing sector vs. 8 declining sectors Market Breadth: Negative (11% advance rate) Interpretation: Risk-off week; only financials held ground
Indian equity markets extended losses for the second consecutive session on Thursday, February 13, 2026, with benchmark indices closing sharply lower amid broad-based selling pressure.
Mankind Pharma is India’s 4th largest pharmaceutical company by domestic market value, with a diversified presence across prescription pharmaceuticals, consumer healthcare/OTC, and exports.
